Quality Control Laboratory Compliance - cGMPs and GLPs: One and a Half-day In-person Seminar (San Francisco, CA, United States - August 30-31, 2018)

  • ID: 4471807
  • Conference
  • Location: San Francisco, CA, United States
  • 2 Days
  • Compliance Online
  • Conference Dates: August 30-31, 2018
1 of 5

FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.

This course will examine the fundamental requirements for all QC laboratories subject to FDA inspection, recent trends from FDA inspection reports and enforcement actions. In addition, this course will include a list of relevant regulations and guidelines and demonstrate how quality control and quality assurance personnel can monitor industry practices to stay “current” with FDA requirements (cGMPs and GLPs).

Learning Objectives:

Key goals of the conference will include learning:
  • The basics of FDA law and regulations governing QC laboratories responsible for testing research materials, components of FDA-regulated products, and finished FDA-regulated products (pharmaceuticals, biologics, medical devices, cosmetics, and foods).
  • Laboratory organization, personnel qualification and training requirements.
  • Documentation and record-keeping requirements, including e-records and data integrity.
  • Sample integrity requirements.
  • Management and control of stability (shelf-life) studies.
  • Analytical methods verification and validation.
  • Management and control of laboratory instruments.
  • Management and control of laboratory supplies.
  • Proper conduct of laboratory investigations.
  • Consequences of laboratory non-compliance.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

Day 01 (8:30 AM - 4:30 PM)

08.30 AM - 09.00 AM: Registration

09.00 AM: Session Start

Basics of FDA law and regulations for QC laboratories

  • What is adulteration?
    • Pharmaceuticals
    • Biologics
    • Medical Devices
    • Foods
    • Cosmetics
  • What is CGMP?
    • Pharmaceuticals
    • Biologics
    • Medical Devices
    • Foods
    • Cosmetics
  • What is GLP?
  • What is AIP?
  • Contract Laboratories
  • FDA inspection methodology

Laboratory Organization

  • Organization
  • Personnel qualification and training

Documentation and record-keeping requirements

  • Standard Operating Procedures
  • Analytical Methods
  • Raw data (notebooks, print-outs)
  • Document management (change control, retention)
  • Part 11 (electronic records and signatures)

Sample integrity requirements

  • Sample collection
  • Sample delivery, handling, disposition
  • Retain samples

Stability (shelf-life) studies

  • Organization and management
  • Storage units
  • Analytical methodology

Day 02 (8:30 AM - 1:00 PM)

Analytical methods verification and validation

  • Protocols
  • Tests
  • Documentation

Management and control of laboratory instruments

  • Qualification
  • Calibration
  • Maintenance

Management and control of laboratory supplies

  • Standards
  • Reagents, chemicals

Proper conduct of laboratory investigations

  • Out-of-specification results
  • Out-of-norm results
  • Root cause analysis
  • Documentation

Consequences of laboratory non-compliance

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Robert C Fish Mr Robert C Fish,
    Consultant ,
    EAS Consulting Group, LLC


    Mr. Fish has been providing independent consulting services since 2003, joining EAS Consulting Group, LLC in November 2006. Prior to that he started work for AAC Consulting Group, Inc. (AAC) in April 1995 after serving 33 years with Food and Drug Administration (FDA). The last 6 years of that service he held the position of Director, Division of Field Investigations (DFI). He was responsible for general policy and guidance for the Agency’s domestic and international investigation activities. He also managed the foreign inspections' operations. Prior to that position, Mr. Fish was Director of Compliance at the Nashville District Office for 8 years and was also a Supervisory Investigator at the Nashville District Office for 8 years.

    Mr. Fish began his career as an investigator in the Minneapolis District Office in 1962, and subsequently served as an Investigator at the Grand Rapids Residence Post and the Detroit District Office. Mr. Fish is experienced in all aspects of FDA regulated products. He has expertise in compliance matters and Current Good Manufacturing Practice Regulations (GMPs) as they relate to pharmaceutical, dietary supplements, tobacco, device, and biologics manufacture. Further, Mr. Fish is ISO 9000 Lead Assessor Trained and is an AFDO Certified HACCP Instructor.

Note: Product cover images may vary from those shown
5 of 5

Who will Benefit:

Senior directors, managers, supervisors and those who have responsibility for ensuring that QC laboratory operations and practices comply with current good manufacturing practices and good laboratory practices.

  • Quality Assurance
  • Quality Control
  • Research & Development
Note: Product cover images may vary from those shown
6 of 5

ADDRESS

San Francisco, CA
United States

Venue to be announced shortly.

Note: Product cover images may vary from those shown
Adroll
adroll